PANGYO, South Korea--(BUSINESS WIRE)--CHA Medical & Bio Group officially began construction of its Cell Gene Biobank (CGB) facility in Pangyo, South Korea. Investing over $250 million in the project, ...
The largest shareholder of Kakao Healthcare, a subsidiary of Kakao, will change to CHA CareS of CHA Bio Group. Kakao Healthcare is currently a 100% subsidiary of Kakao, but through Kakao's sale of ...
CHA Bio Group signed a memorandum of understanding with U.S.-based Cambridge Innovation Center (CIC) to establish an open innovation center focused on research and innovation within currently-building ...